USP39 and neoplasm: The role of USP39 in indirectly affecting tumor progression by regulating key proteins of the MAPK pathway provides a new means and direction for the treatment of poorly differentiated refractory melanoma in the clinic, and targeted inhibitors of USP39 are worthy of further investigation.